Tuberculosis and HIV co-infection

Medicine

Volumn 37, Issue 12, 2009, Pages 654-656

  Lawn, Stephen D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

AIDS; antiretroviral treatment; HIV; immune reconstitution; immunodeficiency; immunopathology; opportunistic infection; tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; GAMMA INTERFERON; PROTEINASE INHIBITOR; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUBERCULIN; TUBERCULOSTATIC AGENT;

BACTERIUM CULTURE; BONE MARROW EXAMINATION; CLINICAL EXAMINATION; DRUG BLOOD LEVEL; FEVER; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; LUNG LAVAGE; LYMPH NODE BIOPSY; MIXED INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK FACTOR; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS; URINE CULTURE;

EID: 70450260943     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2009.09.005     Document Type: Review

References (10)

1. Corbett E.L., Watt C.J., Walker N., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163 (2003) 1009-1021
2. World Health Organization. Global tuberculosis control 2009. Epidemiology, strategy, financing (2009), World Health Organization, Geneva. http://www.who.int/tb/publications/global_report/2009/en/index.html WHO/HTM/TB/2009.411. Accessible at:
3. Wells C., Cegielski P., Nelson L., et al. HIV infection and multidrug-resistant tuberculosis - the perfect storm. J Infect Dis 196 (2007) S86-S107
4. Lawn S.D., Butera S.T., and Shinnick T.M. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 4 (2002) 635-646
5. Perkins M.D., and Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196 (2007) S15-S27
6. Pozniak A.L., Collins S., Coyne K.M., et al., on behalf of the BHIVA Guidelines Writing Committee. British HIV Association guidelines for the treatment of TB/HIV co-infection. Accessible at: (2009). http://www.bhiva.org/cms1223707.asp
7. Lawn S.D., Bekker L.G., and Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS 19 (2005) 1113-1124
8. McIlleron H., Meintjes G., Burman W.J., and Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 196 (2007) S63-S75
9. Lawn S.D., Bekker L.G., and Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5 (2005) 361-373
10. Lawn S.D., Wilkinson R.J., Lipman M.C., and Wood R. Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 177 (2008) 680-685